Literature DB >> 214511

In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

L Slaughter, D A Carson, F C Jensen, T L Holbrook, J H Vaughan.   

Abstract

Peripheral blood mononuclear cells from 10 patients with rheumatoid arthritis and 9 control subjects were cultured in vitro for 30 days with and without infection by Epstein-Barr virus. All cultures showed polyclonal stimulation of B cells as indicated by rising levels of IgM in the culture supernates, reaching maximal at 18-24 days, and with no quantitative or kinetic difference between the RA and control cells. IgM anti-IgG was also produced in both groups and maximally at 18-24 days, but in greater quantity by the RA lymphocytes. The anti-IgG made by the RA lymphocytes was more easily absorbed by solid phase IgG than was the anti-IgG made by the normal lymphocytes and thus was judged to be of higher affinity. RA lymphocytes uninfected with EBV had higher transformation scores than did the normal controls and developed spontaneously into permanent cell lines in six instances.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214511      PMCID: PMC2185048          DOI: 10.1084/jem.148.5.1429

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Lymphoma, immunodeficiency and the Epstein-Barr virus.

Authors:  F S Rosen
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

2.  Induction of plaque-forming cells in cultured human lymphocytes by combined action of antigen and EB virus.

Authors:  A L Luzzati; H Hengartner; M H Schreier
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

3.  Efficiency of transformation of lymphocytes by Epstein-Barr virus.

Authors:  E Henderson; G Miller; J Robinson; L Heston
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

4.  Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.

Authors:  G Klein; L Dombos
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

5.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

6.  Studies on monoclonal antibodies. I. The specificity and binding properties of a Waldenström macroglobulin with anti- G activity.

Authors:  M J Stone
Journal:  J Lab Clin Med       Date:  1973-03

7.  Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis.

Authors:  F A Wollheim; R C Williams
Journal:  N Engl J Med       Date:  1966-01-13       Impact factor: 91.245

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

10.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  68 in total

Review 1.  Lymphocyte function and virus infections.

Authors:  A M Denman
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

Review 2.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Soluble CD23 levels and their correlation with erythrocyte sedimentation rate and with copy number of Epstein-Barr virus genome in rheumatoid arthritis patients.

Authors:  S Sawada; K Mitamura; M Takei; T Okubo; S Fujiwara
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 4.  B cell clones in rheumatoid arthritis.

Authors:  M Steinitz
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.

Authors:  T Häupl; G R Burmester; G Hahn; U Feige; C Rordorf-Adam; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

6.  B-lymphocyte activation with an extract of Nocardia brasiliensis.

Authors:  L Ortiz-Oritz; D E Parks; J S Lopez; W O Weigle
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

7.  Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients.

Authors:  P V Shirodaria; K B Fraser; M Armstrong; S D Roberts
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

8.  Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families.

Authors:  G S Alarcón; B O Barger; R C Go; R T Acton; R E Schrohenloher; W J Koopman
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

9.  Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.

Authors:  G Tosato; A D Steinberg; R Yarchoan; C A Heilman; S E Pike; V De Seau; R M Blaese
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 10.  Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.

Authors:  Y W Song; E H Kang
Journal:  QJM       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.